315
Participants
Start Date
June 30, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
January 31, 2015
Saxagliptin
Tablets, Oral, 5 mg, Once daily, Up to 52 weeks
Dapagliflozin
Tablets, Oral, 10 mg, Once daily, Up to 52 weeks
Metformin IR
Tablets, Oral, ≥ 1500mg, Twice daily, Up to 52 weeks
Placebo matching with Saxagliptin
Tablets, Oral, 0 mg, Once daily, Up to 52 weeks
Local Institution, Budapest
Local Institution, Budaörs
Clinical Research Advantage, Evansville
Local Institution, Zalaegerszeg
N. Shore Diabetes & Endoc Assoc, New Hyde Park
Digiovanna Institute For Medical Education & Research, North Massapequa
Barat Research Group, Inc., Charlotte
Tlm Medical Services, Columbia
Family Medicine Of Sayebrook, Myrtle Beach
University Of Florida Endocrinology & Diabetes, Jacksonville
Care Partners Clinical Research, Llc, Jacksonville
Southeast Clinical Research, Llc, Chiefland
Medical Research Unlimited, Llc, Hialeah
Clinical Research Of Miami, Inc., Miami
Clinical Therapeutics Corporation, Coral Gables
University Of Alabama At Birmingham, Birmingham
Terence T. Hart, Md, Muscle Shoals
Vanderbilt Diabetes Center, Nashville
Holston Medical Group, Bristol
Local Institution, Katowice
Physicians Research, Inc., Zanesville
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Guadalajara
Sterling Research Grp, Ltd., Cincinnati
Clinical Research Advantage, Inc., Evansville
Local Institution, Morelia
Mercy Health Research, St Louis
Local Institution, Monterrey
Local Institution, Bucharest
Padre Coast Clinical Research, Corpus Christi
New West Physicians, Pc, Golden
Clinical Research Advantage, Inc, Phoenix
Clinical Research Advantage, Inc./ Stonecreek Medical Associates, Pc, Phoenix
Mesa Family Medical Center, Mesa
Clinical Research Advantage Inc/Desert Clinical Research Llc, Mesa
Clinical Research Advantage, Inc., Las Vegas
Randall G. Shue, Do, Inc., Los Angeles
National Research Institute, Los Angeles
Torrance Clinical Research, Lomita
Infosphere Clinical Research, Inc., West Hills
Local Institution, Veracruz
Cassidy Medical Group/Clinical Research Advantage, Vista
Beach Physicians Clinical Research Corp., Huntington Beach
Local Institution, Ploieşti
Local Institution, Moscow
Local Institution, Yaroslaval
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Craiova
Local Institution, Kursk
Local Institution, Brasov
Local Institution, Galati
Local Institution, Constanța
Joslin Diabetes Center Affiliate Of Snhmc, Nashua
Local Institution, Moncton
Local Institution, St. John's
Local Institution, Halifax
Local Institution, Brampton
Local Institution, Sarnia
Local Institution, Montreal
Local Institution, Québec
Local Institution, Hradec Králové
Local Institution, Karlovy Vary
Local Institution, Prague
Local Institution, Balatonfüred
Local Institution, Del. Benito Juarez
Local Institution, Bialystok
Local Institution, Katowice
Local Institution, Krakow
Local Institution, Pszczyna
Local Institution, Puławy
Local Institution, Szczecin
Local Institution, Warsaw
Local Institution, Węgrów
Local Institution, Wroclaw
Research & Cardiovascular Corp, Ponce
Local Institution, Bucharest
Local Institution, Bucharest
Lead Sponsor
AstraZeneca
INDUSTRY